Sterling340B

What Sterling340B does

Sterling340B is a private US consulting firm that advises independent pharmacies on the federal 340B Drug Pricing Program. A wholly-owned subsidiary of Astrup Companies — a family-owned conglomerate founded in 1952 that operates nearly two dozen retail, long-term care, and specialty pharmacies — Sterling340B was established to commercialize the parent group's firsthand operational experience with 340B economics. The firm does not develop proprietary software or a technology platform; its core product is individualized human advisory work delivered to each pharmacy on a one-off or quarterly basis.

The service menu is structured around five engagement types: 340B Contract Pharmacy Consulting, Dispense Fee Modeling & Pharmacy Services Agreement (PSA) Review, Contract Review with covered entities (with emphasis on DIR fee protections), DIR Impact Review (including inventory swell and cash-flow diagnostics), and recurring Quarterly Analysis & Ongoing Support. Sterling340B does not publish pricing; engagements are quoted on a per-pharmacy basis, with revenue earned as professional-services fees.

The go-to-market is sales-led and US-domestic-only. Lead generation relies on educational website content and a downloadable handout ("Transparent. Personal. Profitable."), with conversion handled through a dedicated contact form and direct executive outreach by Matt Sneller, PharmD, the firm's senior consultant and a former executive at a 340B third-party administrator. Sterling340B holds a registered trademark on its brand name and operates from 905 N Main St, Austin, Minnesota. No external funding, M&A activity, geographic expansion, or AI capabilities are disclosed.

Name

Sterling340B

Legal name

Sterling340B

Website

https://sterling340b.com

Company type

Private

Founded year

2019

Operating status

Operating

Headcount range

11–50 employees

Short description

Sterling340B is a private US consulting firm, a subsidiary of Astrup Companies, that advises independent pharmacies on the federal 340B Drug Pricing Program. It offers contract pharmacy consulting, dispense fee modeling, DIR impact review, contract review, and recurring quarterly analysis on a fee basis.

Ownership category

akta.pro rank

Product category

Pharmacy 340B Program Consulting

NAICS

Management Consulting Services (54161)

akta.pro primary industry

340B Program Administration & Contract Pharmacy Services (HLAFALAL)

akta.pro secondary industries

340B Program Administration & Support (HLAEAKAJ), Pharmacy Benefit/Channel Services (PSAO, 340B Admin, Chargebacks/Rebates Ops) (CRAOAHAK)

Keywords

• 340B consulting services
• Contract pharmacy advisory
• Pharmacy program optimization
• DIR fee analysis
• Independent pharmacy services

Headquarters

HQ city

Austin

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

1. 340B Consulting Services: Sterling340B generates revenue through consulting services for independent pharmacies seeking to optimize their 340B contract pharmacy programs. The company provides evaluation, contract review, DIR impact analysis, and ongoing support services on a fee basis.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Sterling340B is a consulting services firm that helps independent pharmacies navigate and optimize their 340B contract pharmacy programs. The company provides individualized advisory services including consultant evaluation, dispense fee modeling and pharmacy services agreement review, contract review with covered entities, DIR fee impact analysis, and ongoing quarterly analysis and support. Services are tailored to each pharmacy's specific operational and financial circumstances rather than delivered as an off-the-shelf product.

Product overview

Sterling340B is a consulting services firm (not a software company) that provides 340B contract pharmacy advisory services to independent pharmacies. The company offers a suite of distinct consulting and analytical service offerings: 340B Contract Pharmacy Consulting Services (core advisory), Dispense Fee Modeling & PSA Review, Contract Review, DIR Impact Review, and Quarterly Analysis & Ongoing Support. Rather than a unified software platform, the product portfolio consists of individualized consulting engagements and recurring analytical services tailored to each pharmacy's specific circumstances.

Differentiator

Problem solved

Functional benefit

Products and services

• 340B Contract Pharmacy Consulting Services Advisory services helping independent pharmacies navigate the complexities of the 340B contract pharmacy program, optimize program design, and maximize profitability through individualized pharmacy-specific guidance.
• Dispense Fee Modeling and PSA Review Analysis of how 340B affects wholesaler cost of goods and rebate contracts, evaluating dispense fee structures and pharmacy services agreement terms.
• Contract Review
• DIR Impact Review
• Quarterly Analysis and Ongoing Support

Named customers1 record

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• Astrup CompaniescoreOthersSterling340B is a subsidiary of Astrup Companies, a family-owned business founded in 1952 by Leonard Astrup. Astrup Companies consists of nearly two dozen independent retail, long-term care, and specialty pharmacies, providing Sterling340B with extensive operational experience in pharmacy management and 340B program challenges.

Scale indicators1 record

Expansion highlights4 records

Broad incumbents

• Apexus: Apexus is HRSA's 340B Prime Vendor, offering educational resources, pricing tools, and program guidance across the 340B ecosystem. It addresses the same buyer (340B participants) but as a broad, federally-contracted incumbent rather than a boutique consultancy.
• McKesson 340B Solutions: McKesson is a major pharmaceutical distributor that offers 340B program services through its Macro Helix subsidiary (now under McKesson) and broader pharmacy services portfolio. It overlaps with Sterling340B's space as a broad incumbent with significantly greater scale.
• Avita Pharmacy: Avita is a 340B-focused specialty and contract pharmacy operator that serves covered entities directly. It competes in the 340B contract pharmacy ecosystem rather than as a pure advisory firm, but addresses the same independent-pharmacy buyer set.

Direct peers

• Visante: Visante is a pharmacy management consulting firm that advises hospitals, health systems, and pharmacies on 340B program optimization, contract pharmacy arrangements, and specialty pharmacy strategy. It is one of the closest direct competitors in pure 340B consulting.
• CaptureRx: CaptureRx is a 340B solutions provider that helps covered entities and contract pharmacies operate compliant, profitable 340B programs. It directly competes with Sterling340B by serving contract pharmacies with split-billing and program optimization services.
• Macro Helix: Macro Helix provides 340B software and services to covered entities and contract pharmacies, including split-billing, dispense-fee modeling, and DIR analytics—closely aligned with Sterling340B's analytical service offerings.
• SunRx: SunRx is a 340B third-party administrator that partners with covered entities and contract pharmacies to manage program operations. It is a directly comparable 340B TPA model that competes for the same independent pharmacy clients.
• Sentry Data Systems: Sentry Data Systems offers 340B software platforms (e.g., Sentry 340B) that automate split-billing and compliance for contract pharmacies. It competes with Sterling340B on dispense-fee modeling and DIR impact analysis, though via software rather than consulting.
• Wellpartner: Wellpartner is a 340B contract pharmacy solutions provider offering inventory management and program compliance services. It serves independent pharmacies entering 340B arrangements, overlapping directly with Sterling340B's target customer and value proposition.

Emerging players

• Pharmacies Service Co. (PSC): PSC is a Pharmacy Services Administrative Organization (PSAO) that negotiates third-party contracts and provides operational support to independent pharmacies. It addresses an adjacent need set—independent pharmacy channel services—with some overlap on dispense-fee and contract review work.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sterling340B